The integrins, Genome Biology, vol.8, issue.5, p.215, 2007. ,
DOI : 10.1186/gb-2007-8-5-215
Regulation of Cell Adhesion and Anchorage-dependent Growth by a New Beta 1-integrin-linked Protein Kinase, Nature, vol.379, issue.6560, pp.91-96, 1996. ,
Integrin antagonists, Cellular and Molecular Life Sciences (CMLS), vol.56, issue.5-6, pp.5-6, 1999. ,
DOI : 10.1007/s000180050443
Integrins, Cell, vol.110, issue.6, pp.673-687, 2002. ,
DOI : 10.1016/S0092-8674(02)00971-6
Integrins, Cell and Tissue Research, vol.137, issue.1, pp.269-280, 2009. ,
DOI : 10.1002/(SICI)1097-0177(199612)207:4<355::AID-AJA1>3.0.CO;2-G
Integrin activation and structural rearrangement, Immunological Reviews, vol.93, issue.1 ,
DOI : 10.1074/jbc.273.44.28937
Vascular integrins: pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis, Cellular and Molecular Life Sciences, vol.60, issue.6, pp.1135-1157, 2003. ,
DOI : 10.1007/s00018-003-2297-3
Linking integrin conformation to function, Journal of Cell Science, vol.122, issue.2, pp.165-170, 2009. ,
DOI : 10.1242/jcs.018556
URL : http://jcs.biologists.org/content/joces/122/2/165.full.pdf
Crystal Structure of the Extracellular Segment of Integrin Alpha Vbeta3, Science, vol.294, issue.5541, pp.339-345, 2001. ,
Integrins: a role as cell signalling molecules, Molecular Pathology, vol.52, issue.4, pp.208-213, 1999. ,
DOI : 10.1136/mp.52.4.208
NEW EMBO MEMBER'S REVIEW: Role of integrins in regulating epidermal adhesion, growth and differentiation, The EMBO Journal, vol.21, issue.15, pp.3919-3926, 2002. ,
DOI : 10.1093/emboj/cdf399
Endothelial cell migration on fibronectin is regulated by syntaxin 6-mediated {alpha}5{beta}1 integrin recycling, The Journal of Biological Chemistry, 2011. ,
The switchable integrin adhesome, Journal of Cell Science, vol.123, issue.9, pp.1385-1388, 2010. ,
DOI : 10.1242/jcs.066183
Components of Cell-matrix Adhesions, Journal of Cell Science, vol.114, pp.3577-3579, 2001. ,
Integrin traffic, Journal of Cell Science, vol.119, issue.18, pp.3723-3731, 2006. ,
DOI : 10.1242/jcs.03216
URL : http://jcs.biologists.org/content/joces/119/18/3723.full.pdf
Integrin Trafficking and the Control of Cell Migration, Traffic, vol.16, issue.Suppl. 1 ,
DOI : 10.1091/mbc.10.1.47
Role of Integrins in Cancer: Survey of Expression Patterns, Proceedings of the Society for Experimental Biology and Medicine, vol.222, issue.2 ,
DOI : 10.1046/j.1525-1373.1999.d01-122.x
Integrins in cancer: biological implications and therapeutic opportunities, Nature Reviews Cancer, vol.13, issue.1, pp.9-22, 2010. ,
DOI : 10.1593/neo.08740
Changes in Integrin and E-cadherin Expression in Neoplastic Versus Normal Thyroid Tissue, Journal of the National Cancer Institute, vol.88, issue.7, pp.442-449, 1996. ,
Integrin alpha 5 beta 1 expression negatively regulates cell growth: reversal by attachment to fibronectin., Molecular Biology of the Cell, vol.6, issue.6, pp.725-740, 1995. ,
DOI : 10.1091/mbc.6.6.725
A Tumorassociated Beta 1 Integrin Mutation That Abrogates Epithelial Differentiation Control, The Journal of Cell Biology Feb, vol.17, issue.1604, pp.589-596, 2003. ,
Identification of a Novel Truncated alphaIIb ,
Cancer Research, pp.4771-4775, 1998. ,
Integrin signalling during tumour progression, Nature Reviews Molecular Cell Biology, vol.15, issue.10, pp.816-826, 2004. ,
DOI : 10.1101/gad.903001
Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling, Journal of Clinical Investigation, vol.119, issue.2, pp.252-256, 2009. ,
DOI : 10.1172/JCI37160DS1
Integrins in angiogenesis and lymphangiogenesis, Nature Reviews Cancer, vol.99, issue.8, pp.604-617, 2008. ,
DOI : 10.1172/JCI200422087
Integrin ?4?1 Signaling Is Required for Lymphangiogenesis and Tumor Metastasis, Cancer Research, vol.70, pp.3042-3051, 2010. ,
Hypoxia signalling in cancer and approaches to enforce tumour regression, Nature, vol.9, issue.suppl. 5, pp.437-443, 1792. ,
DOI : 10.1016/j.devcel.2005.09.010
WHO Classification of Tumours of the Central Nervous System, Fourth Edition. IARC WHO Classification of Tumours, 2007. ,
Classification histologique et moléculaire des gliomes, Revue Neurologique, vol.164, pp.505-515, 2008. ,
Neuropathology and molecular pathology of gliomas ,
Molecular diagnostics of gliomas: state of the art, Acta Neuropathologica, vol.324, issue.5, pp.567-584, 2010. ,
DOI : 10.1093/neuonc/nop020
The neurobiology of gliomas: from cell biology to the development of therapeutic approaches, Nature Reviews Neuroscience, vol.18, issue.9, pp.495-508, 2011. ,
DOI : 10.1111/j.1750-3639.2008.00136.x
Radiation therapy treatment planning in supratentorial glioblastoma multiforme: An analysis based on post mortem topographic anatomy with ct correlations, International Journal of Radiation Oncology*Biology*Physics, vol.17, issue.6, pp.1347-1350, 1989. ,
DOI : 10.1016/0360-3016(89)90548-8
Angiogenesis in brain tumors; pathobiological and clinical aspects, Journal of Neuro-Oncology, vol.32, issue.3, pp.253-265, 1997. ,
DOI : 10.1023/A:1005746320099
Malignant Gliomas in Adults, New England Journal of Medicine, vol.359, issue.5, pp.492-507, 2008. ,
DOI : 10.1056/NEJMra0708126
Gliomagenesis: genetic alterations and mouse models, Nature Reviews Genetics, vol.59, issue.2, pp.120-139, 2001. ,
DOI : 10.1101/gad.12.23.3675
Synthesis and positron emission tomography studies of carbon-11-labeled imatinib (Gleevec), Nuclear Medicine and Biology, vol.34, issue.2, pp.153-63, 2007. ,
DOI : 10.1016/j.nucmedbio.2006.11.004
Phase II trial of gefitinib in recurrent glioblastoma, J Clin Oncol, vol.22, issue.1, pp.133-175, 2004. ,
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma, J Clin Oncol, 2009. ,
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib, N Engl J Med, vol.350, issue.50, pp.2129-2139, 2004. ,
Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study ,
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors, N Engl J Med, vol.353, pp.2012-2024, 2005. ,
Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology: Hopes and Disappointments, Clinical Cancer Research, vol.14, issue.4, pp.957-960, 2008. ,
DOI : 10.1158/1078-0432.CCR-07-1810
Lessons learned in the development of targeted therapy for malignant gliomas, Molecular Cancer Therapeutics, vol.6, issue.7, pp.1909-1919, 2007. ,
DOI : 10.1158/1535-7163.MCT-07-0047
Bevacizumab and irinotecan in recurrent malignant glioma, Clin Cancer Res, vol.13, pp.1253-1259, 2007. ,
Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas, Clin Cancer Res, vol.14, issue.21, pp.7068-7073, 2008. ,
Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma, Clin Oncol, 2007. ,
Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence, Neurology, vol.70, issue.10, pp.779-787, 2008. ,
Phase II Pilot Study of Bevacizumab in Combination with Temozolomide and Regional Radiation Therapy for Up-Front Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Interim Analysis of Safety and Tolerability, International Journal of Radiation Oncology*Biology*Physics, vol.71, issue.5, pp.1372-1380, 2008. ,
DOI : 10.1016/j.ijrobp.2007.11.068
Expression of integrin alphavbeta3 in gliomas correlates with tumor grade and is not restricted to tumor vasculature, Brain Pathol, vol.18, issue.3, pp.378-386, 2008. ,
Characterization of integrin receptors in normal and neoplastic human brain, Am J Pathol, vol.143, issue.1, pp.154-163, 1993. ,
Expression of integrin alpha6beta1 enhances tumorigenesis in glioma cells, Am J Pathol, vol.175, issue.2, pp.844-855, 2009. ,
Cilengitide: an integrin-targeting arginine???glycine???aspartic acid peptide with promising activity for glioblastoma multiforme, Expert Opinion on Investigational Drugs, vol.62, issue.8 ,
DOI : 10.1054/bjoc.2000.1316
Integrins as Target: First Phase III Trial Launches, but Questions Remain, JNCI: Journal of the National Cancer Institute, vol.102, issue.10 ,
DOI : 10.1093/jnci/djq186
URL : https://academic.oup.com/jnci/article-pdf/102/10/675/18085466/djq186.pdf
Alpha5beta1 integrin antagonists reduce chemotherapy-induced premature 104 ,
Involvement of TGF? pathway in the regulation of ?(5) ?(1) integrins by caveolin-1 in human glioblastoma, Int J Cancer, 2011. ,
Role of Caveolae and Caveolins in Health and Disease, Physiological Reviews, vol.84, issue.4, pp.1341-1379, 2004. ,
DOI : 10.1073/pnas.172360799
Models for neuro-oncological preclinical studies: solid orthotopic and heterotopic grafts of human gliomas into nude mice, Journal of Neuroscience Methods, vol.125, issue.1-2, pp.147-157, 2003. ,
DOI : 10.1016/S0165-0270(03)00043-8
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2???????CT Method, Methods, vol.25, issue.4, pp.402-408, 2001. ,
DOI : 10.1006/meth.2001.1262
Histological classification of human gliomas: state of art and controversies, Bulletin Du Cancer, vol.92, pp.301-309, 2005. ,
Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas, Cancer, vol.88, issue.7 ,
DOI : 10.1037/0033-2909.86.5.974
Fibrinogen binds to integrin alpha(5)beta(1) via the carboxyl-terminal RGD site of the Alpha-chain, J Biochem, vol.128, issue.4, pp.705-715, 2000. ,
Plasma and cellular fibronectin: distinct and independent functions during tissue repair, Fibrogenesis & Tissue Repair, vol.4, issue.1, p.21, 2011. ,
DOI : 10.1097/01.ASN.0000051600.53134.B9
URL : http://europepmc.org/articles/pmc3182887?pdf=render
Adhesion Mechanisms in Platelet Function, Circulation Research, vol.100, issue.12, pp.1673-1685, 2007. ,
DOI : 10.1161/01.RES.0000267878.97021.ab
Celladhesion molecules in human meningiomas: correlation with clinical and morphological data ,
Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma, Cancer Research, vol.69, issue.8, pp.3308-3316, 2009. ,